This site has been optimized to work with modern browsers and does not fully support your version of Internet Explorer.

Spread and adoption

The NHS Long Term Plan committed to accelerate the uptake of selected innovative medical devices, diagnostics and digital products to patients faster, by developing the MedTech Funding Mandate (MTFM) policy, which is delivered in partnership with AHSNs. Launched in April 2021 the MTFM supports four products:

  • Placental growth factor based testing (PlGF) to rule out pre-eclampsia – the Oxford AHSN initiated this work
  • SecurAcath – a device to secure peripherally inserted central catheters for medium to long stay patients
  • HeartFlow FFRCT – estimates fractional flow reserve from coronary CT angiography for stable recent chest pain, avoiding invasive investigation and treatment
  • gammaCore – non-invasive self-administered vagus nerve stimulator to treat and prevent cluster headaches